Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat

Stryker‘s (NYSE:SYK) Homedica is on the hook for approximately $13.3 million in attorney’s fees and $513,258 in costs due to Zimmer Biomet (NYSE:ZBH) as a result of a patent dispute, according to recently unsealed court documents.